Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies.

Taylor, Zachary L; Vang, Jesper; Lopez-Lopez, Elixabet; Oosterom, Natanja; Mikkelsen, Torben; Ramsey, Laura B

Taylor, Zachary L; Vang, Jesper; Lopez-Lopez, Elixabet; Oosterom, Natanja; Mikkelsen, Torben; Ramsey, Laura B.

Afiliación

Taylor ZL; Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH 45267, USA.
Vang J; Division of Research in Patient Services, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Lopez-Lopez E; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Oosterom N; Department of Health Technology, Technical University of Denmark, 2800 Lyngby, Denmark.
Mikkelsen T; Paediatric Oncology Research Laboratory, University Hospital of Copenhagen, Rigshospitalet Blegdamsvej 9, 2100 Copenhagen, Denmark.
Ramsey LB; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country, UPV/EHU, 48940 Leioa, Spain.

Cancers (Basel) ; 13(11)2021 Jun 07.

Article en En | MEDLINE | ID: mdl-34200242

Palabras clave

acute lymphoblastic leukemia; lymphoma; methotrexate; osteosarcoma; pediatrics; pharmacogenetics; pharmacokinetics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google